National Comprehensive Cancer Network

Educational Events & Programs

NCCN Academy for Excellence & Leadership in Oncology™
School of Pharmaceutical & Biotech Business

Use and Impact of Information Products on Decision-Makers in Cancer Care

Experienced Module

This module highlights specific cases illustrating the types and amounts of data needed to influence provider and payor organizations and may include the following topics:

  • Analysis of the value of specific clinical outcomes, the design, size, and publication status of studies, and the influence and type of cost data used in decisions
  • Crucial issue of use of drugs and biologics beyond the FDA-approved label, with a particular emphasis on practice guidelines and drug compendia
  • Candid discussion on the "dos" and "don'ts" of interacting with organizations that develop information products
  • The integration of information into decision-assist tools designed to be used by clinicians, patients, or payors
  • The role of information products in clinical treatment decisions and the design of disease management programs
  • The role of informatics tools such as EMR and CPOE in oncology, with a particular emphasis on how these tools may influence the use of drugs and biologics in clinical settings
  • New programs which may impact use of agents in the foreseeable future
  • The process of new agent incorporation into NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®)